본문 바로가기
KERD
논문KCI 등재

국내 한 대학병원의 임상검체에서 분리된 Bacteroides fragilis 독소 유전자의 특성

Characterization of bft Genes among Enterotoxigenic Bacteroides fragilis Isolates from Extraintestinal Specimens at a University Hospital in Korea

권선영|김현수|임정훈|이경원|김완희|이기종|김명숙|지승은
대한임상검사과학회 (Korean Society for Clinical Laboratory Science)|2016.06|대한임상검사과학회지 (Korean Journal of Clinical Laboratory Science)|제48권 제2호|pp. 82-87

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

Antimicrobial resistanceBacteroides fragilis toxinEnterotoxigenic Bacteroides fragilisbft gene isotype
주제분류기타자연과학

초록

Enterotoxigenic Bacteroides fragilis (ETBF)는 병독소 인자로알려진 장독소를 생성하는 균종이다. B. fragilis enterotoxin (BFT)은 bft-1, bft-2 및 bft-3 세 개의 유전자 아형들이 밝혀졌다. 본 연구에서는 임상 검체에서 분리된 B. fragilis에서 bft 유전자의유무와 BFT 음성 및 양성 균주의 항균제 내성을 조사하였다. 국내의 한 대학병원에서 8년간(2006∼2013년) 장외 검체에서 분리된B. fragilis는 총 537주이었다. 다중중합연쇄반응으로 시험하여 bft 유전자 아형을 확인하였다. BFT 음성 74주와 양성 33주를 포함한B. fragilis 107주의 항균제 감수성은 CLSI 한천희석법으로 시험하였다. 임상 검체에서 분리된 B. fragilis의 bft 유전자 검출율은 30% 이었고, 이 중 혈액과 혈액 외 장외 검체 분리주에서는 각각 33%, 29% 이었다. ETBF 중에서 가장 흔한 아형은 bft-1 이었고, 그 다음은 bft-2, bft-3 순이었다(bft-1: 77%, bft-2: 14%, bft-3: 9%). BFT-음성과 양성 균주의 내성률은 일부 항균제에 대해서 차이가있었다(BFT-음성 균주: piperacillin-tazobactam 3%, cefoxitin 5%, imipenem 1%, clindamycin 38%; BFT-양성 균주: piperacillin-tazobactam 3%, cefoxitin 6%, imipenem 3%, clindamycin 42%). BFT-음성 및 BFT-양성 균주 모두는chloramphenicol과 metronidazole에 대한 내성은 없었다. 결론적으로, 혈액 분리주에서의 ETBF 검출율은 혈액 외 장외 검체 분리주에서와 비슷하였고, 가장 흔한 유전자 아형은 bft-1 이었다. 항균제 내성은 BFT 양성 균주가 음성 균주보다 대체로 높았으나 통계학적으로 유의한 차이는 없었다.

Abstract

Enterotoxigenic Bacteroides fragilis (ETBF) produces enterotoxins known to be a virulence factor. Three isotypes of the B. fragilis toxin (BFT) gene have been identified: bft-1, bft-2, and bft-3. We investigated the presence of bft isotypes in clinical B. fragilis isolates and the antimicrobial resistance of BFT-negative and BFT-positive isolates. Overall, 537 B. fragilis isolates were collected from extraintestinal specimens over 8 years (2006∼2013) from a university hospital in Korea. Samples were analyzed by multiplex PCR to identify the bft gene isotypes. Additionally, the antimicrobial susceptibility of 107 B. fragilis isolates (74 BFT-negative and 33 BFT-positive) was examined by the CLSI agar dilution method. PCR revealed a total bft gene detection rate of 30%, while 33% and 29% of blood and other extraintestinal isolates contained the gene, respectively. Among ETBF isolates, the most common isotype was bft-1 gene, followed by bft-2 and bft-3 (bft-1 77%, bft-2 14%, bft-3 9%). Resistance rates (%) for BFT-negative and positive isolates differed in response to various antimicrobial agents, with 3%, 5%, 1% and 38% of BFT-negative isolates and 3%, 6%, 3% an 42% of BFT-positive isolates being resistant to piperacillin-tazobactam, cefoxitin, imipenem, and clindamycin, respectively. Interestingly, neither BFT-negative nor positive isolates showed antimicrobial resistance to chloramphenicol and metronidazole. Overall, the proportion of ETBF from blood was similar to that of other extraintestinal sites and the bft-1 gene was the predominant isotype. Higher antimicrobial resistance rates were found in BFT-positive isolates than BFT-negative isolates, but these differences were not statistically significant.

참고문헌 (25)

  1. Versalovic J, "Manual of clinical microbiology", pp.858~ (2011), ASM Press
  2. 권선영, "Enterotoxigenic Bacteroides fragilis에 의한 질환과 검출", 대한임상검사과학회지, 47(4), pp.161~167 (2015), 대한임상검사과학회
  3. Myers LL, "Isolation of enterotoxigenic Bacteroides fragilis from humans with diarrhea", J Clin Microbiol, 25, pp.2330~2333 (1987)
  4. Basset C, "Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease?", Dig Dis Sci, 49, pp.1425~1432 (2004)
  5. Toprak NU, "A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer", Clin Microbiol Infect, 12, pp.782~786 (2006)
  6. Wu S, "A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses", Nat Med, 15, pp.1016~1022 (2009)
  7. Chung GT, "Identification of a third metalloprotease toxin gene in extraintestinal isolates of Bacteroides fragilis", Infect Immun, 67, pp.4945~4949 (1999)
  8. Kato N, "A new subtype of the metalloprotease toxin gene and the incidence of the three bft subtypes among Bacteroides fragilis isolates in Japan", FEMS Microbiol Lett, 182, pp.171~176 (2000)
  9. d'Abusco AS, "The alles of the bft gene are distributed differently among enterotoxigenic Bacteroides fragilis strains from human sources and can be present in double copies", J Clin Microbiol, 38, pp.607~612 (2000)
  10. Sears CL, "Enterotoxigenic Bacteroides fragilis : a rougue among symbiotes", Clin Microbiol Rev, 22, pp.349~369 (2009)
  11. Avila-Campos MJ, "Determination of bft gene subtypes in Bacteroides fragilis clinical isolates", J Clin Microbiol, 45, pp.1336~1338 (2007)
  12. Clinical Laboratory Standard Institute, "Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard-eighth edition. CLSI Document M11-A8. Wayne", CLSI, ~ (2012)
  13. 신경섭, "Secular Trends of Species and Antimicrobial Resistance of Blood Isolates in a Tertiary Medical Center for Ten Years: 2003~2012", 대한의생명과학회지, 20(2), pp.77~84 (2014), 대한의생명과학회
  14. Kato N, "Association of enterotoxigenic Bacteroides fragilis with bacteremia", Clin Infect Dis, 23(Suppl 1), pp.S83~S86 (1996)
  15. Foulon I, "Prevalence of fragilysin gene in Bacteroides fragilis isolates from blood and other extraintestinal samples", J Clin Microbiol, 41, pp.4428~4430 (2003)
  16. Toprak NU, "The distribution of the bft alleles among enterotoxigenic Bacteroides fragilis strains from stool specimens and extraintestinal sites", Anaerobe, 12, pp.71~74 (2006)
  17. Nguyen TV, "Diarrhea caused by enteropathogenic Bacteroides fragilis in children less than 5years of age in Hanoi, Vietnam", Anaerobe, 11, pp.109~114 (2005)
  18. Lee Y, "Antimicrobial susceptibility patterns for recent clinical isolates of anaerobic bacteria in South Korea", Antimicrob Agents Chemother, 54, pp.3993~3997 (2010)
  19. Nagy E, "Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe : 20 years of experience", Clin Microbiol Infect, 17, pp.371~379 (2011)
  20. Femandez-Canigia L, "First national survey of antibiotic susceptibility of the Bacteroides fragilis group : emerging resistance to carbapenems in Argentina", Antimicrob Agents Chemother, 56, pp.1309~1314 (2012)
  21. Karlowsky JA, "Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011 : CANWARD surveillance study", Antimicrob Agents Chemother, 56, pp.1247~1252 (2012)
  22. Sears CL, "Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea", Clin infect Dis, 15, pp.797~803 (2008)
  23. Sarkar A, "Detection of integrin-associated gene cassettes and other antimicrobial resistance genes in enterotoxigenic Bacteroides fragilis", Anaerobe, 33, pp.18~24 (2015)
  24. Boyanova L, "Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades", Anaerobe, 31, pp.4~10 (2015)
  25. Gilbert DN, "The Sanford guide to antimicrobial therapy 2015", pp.68~ (2015), Antimicrobial Therapy

이 간행물의 다른 논문 (17건)

대구지역 응급의료센터에 내원한 급성 콩팥손상 환자의 진단을 위한 호중구 젤라티나제 관련 리포칼린 키트의 유용성박상욱, 이승진pp. 49-53LDL Cholesterol 또는 Total Cholesterol의 적용에 따른 Framingham Risk Score와 10년 내 심혈관질환 발생 위험도 평가권세영, 나영악pp. 54-61제주 자생 조록나무 분획물의 항산화 효과정용환, 김혜란, 윤원종, 정보경, 장경수, 박규남pp. 62-67Evaluation of Analyzer and Measurement Conditions of Blood Ammonia김상수, 박창은, 이승모, 김명수pp. 68-73비뇨생식기계 검체로부터 분리된 Ureaplasma 종의 Fluoroquinolone 내성과 관련된 gyrA, gyrB, parC, parE 유전자의 돌연변이 양상황유연, 김성현, 김영권, 구본경, 조은정, 박제섭pp. 74-81
원문 보기